Access Vascular

Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a new approach to thrombus reduction, the company manufactures catheters from a proprietary hydrophilic material designed to evade the foreign body response and the complications that come with it.